Mean global DNA methylation serves as independent prognostic marker in IDH wild type glioblastoma.
Alicia EckhardtRichard DrexlerMelanie SchoofNina StruveDavid CapperClaudius JelgersmaJulia OnkenPatrick N HarterKatharina J WeberIris DivéKai RothkammKonstantin HofferLukas KlumppKatrin GanserCordula PetersenFranz L RicklefsMalte KriegsUlrich SchüllerPublished in: Neuro-oncology (2023)
Our results indicate that mean global DNA methylation is independently associated with outcome in glioblastoma. The data also suggest that a higher DNA methylation is associated with better radiotherapy response and less aggressive phenotype, both of which presumably contribute to the observed correlation with OS.